Centric Wealth Management Maia Biotechnology, Inc. Put Options Transaction History
Centric Wealth Management
- $306 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MAIA
# of Institutions
21Shares Held
661KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA282KShares$938,0010.0% of portfolio
-
Geode Capital Management, LLC Boston, MA53.3KShares$177,3450.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX45.7KShares$152,1810.0% of portfolio
-
Virtu Financial LLC New York, NY32.5KShares$108,1810.01% of portfolio
-
Jane Street Group, LLC New York, NY25.1KShares$83,4660.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $36.4M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...